Beta Bionics, Inc. Shareholders' Equity
Beta Bionics, Inc. (BBNX) had Shareholders' Equity of $256.37 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-29
- 2026-06-30: Stockholders' Equity Attributable to Parent $256.37M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $271.25M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $287.61M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $294.76M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $256.37M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $271.25M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $287.61M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $294.76M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $301.63M 10-Q · filed 2026-07-29 |
| 2025-03-31 | $313.75M 10-Q · filed 2026-07-29 |
| 2024-12-31 | -$245.36M 10-Q · filed 2026-07-29 |
| 2024-09-30 | -$228.85M 10-Q · filed 2025-10-28 |
| 2024-06-30 | -$221.21M 10-Q · filed 2025-10-28 |
| 2024-03-31 | -$214.32M 10-Q · filed 2025-07-29 |
| 2023-12-31 | -$203.10M 10-K · filed 2026-02-24 |
| 2022-12-31 | -$170.03M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |